{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:49:06Z","timestamp":1768920546673,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH000889"],"award-info":[{"award-number":["MH000889"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH002935"],"award-info":[{"award-number":["MH002935"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.nbd.2020.104978","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T09:25:26Z","timestamp":1592645126000},"page":"104978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Regional rates of brain protein synthesis are unaltered in dexmedetomidine sedated young men with fragile X syndrome: A L-[1-11C]leucine PET study"],"prefix":"10.1016","volume":"143","author":[{"given":"Kathleen C.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Loutaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-4368","authenticated-orcid":false,"given":"Zenaide","family":"Quezado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Sheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2722-0180","authenticated-orcid":false,"given":"Carolyn Beebe","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104978_bb0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature11737","article-title":"FMRP targets distinct mRNA sequence elements to regulate protein expression","volume":"492","author":"Ascano","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104978_bb0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mrdd.20007","article-title":"Psychopharmacology in fragile X syndrome--present and future","volume":"10","author":"Berry-Kravis","year":"2004","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.nbd.2020.104978_bb0015","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/jcbfm.2008.43","article-title":"Regional rates of cerebral protein synthesis measured with L-[1-11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility","volume":"28","author":"Bishu","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2020.104978_bb0020","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/jcbfm.2009.7","article-title":"Propofol anesthesia does not alter regional rates of cerebral protein synthesis measured with L-[1-(11)C]leucine and PET in healthy male subjects","volume":"29","author":"Bishu","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2020.104978_bb0025","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1088\/0031-9155\/48\/8\/301","article-title":"The design and implementation of a motion correction scheme for neurological PET","volume":"48","author":"Bloomfield","year":"2003","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.nbd.2020.104978_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.WCB.0000046145.31247.7A","article-title":"Brain uptake of the acid metabolites of F-18-labeled WAY 100635 analogs","volume":"23","author":"Carson","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2020.104978_bb0035","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1101\/gad.1025202","article-title":"Fragile X-related protein and VIG associate with the RNA interference machinery","volume":"16","author":"Caudy","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2020.104978_bb0040","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jnc.14874","article-title":"Effects of the presence and absence of amino acids on translation, signaling, and long-term depression in hippocampal slices from Fmr1 knockout mice","volume":"151","author":"Cooke","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2020.104978_bb0045","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cercor\/bhn159","article-title":"Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome","volume":"19","author":"Curia","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.nbd.2020.104978_bb0050","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/nn.3379","article-title":"The translation of translational control by FMRP: therapeutic targets for FXS","volume":"16","author":"Darnell","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.104978_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.104978_bb0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainres.2006.08.115","article-title":"Decreased expression of the GABAA receptor in fragile X syndrome","volume":"1121","author":"D\u2019Hulst","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.104978_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131486","article-title":"Positron emission tomography (PET) quantification of GABAA receptors in the brain of fragile X patients","volume":"10","author":"D\u2019Hulst","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104978_bb0070","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of fragile X syndrome in mice","volume":"56","author":"Dolen","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2020.104978_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0038-1633887","article-title":"Intensity-based image registration with a guaranteed one-to-one point match","volume":"43","author":"Fischer","year":"2004","journal-title":"Methods Inf. Med."},{"key":"10.1016\/j.nbd.2020.104978_bb0080","first-page":"336","article-title":"Survey of the efficacy of clonidine in fragile X syndrome","volume":"8","author":"Hagerman","year":"1995","journal-title":"Dev. Brain Dysfunct."},{"key":"10.1016\/j.nbd.2020.104978_bb0085","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/ajmg.a.61286","article-title":"Fragile X syndrome in a male with methylated premutation alleles and no detectable methylated full mutation alleles","volume":"179","author":"Hayward","year":"2019","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.nbd.2020.104978_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004218","article-title":"Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen","volume":"4","author":"Henderson","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2020.104978_bb0095","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1101\/gad.1022002","article-title":"A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins","volume":"16","author":"Ishizuka","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.nbd.2020.104978_bb0100","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/ddy099","article-title":"Protein synthesis levels are increased in a subset of individuals with fragile X syndrome","volume":"27","author":"Jacquemont","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.104978_bb0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/hmg\/10.4.329","article-title":"Evidence that fragile X mental retardation protein is a negative regulator of translation","volume":"10","author":"Laggerbauer","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.104978_bb0110","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/nar\/29.11.2276","article-title":"The fragile X mental retardation protein inhibits translation via interacting with mRNA","volume":"29","author":"Li","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2020.104978_bb0115","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.nbd.2011.12.037","article-title":"Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome","volume":"45","author":"Liu","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104978_bb0120","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cell.2008.07.031","article-title":"The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP","volume":"134","author":"Napoli","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.104978_bb0125","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1523\/JNEUROSCI.1714-10.2010","article-title":"Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome","volume":"30","author":"Olmos-Serrano","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104978_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000332884","article-title":"The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome","volume":"33","author":"Olmos-Serrano","year":"2011","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.nbd.2020.104978_bb0135","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.1523\/JNEUROSCI.3888-10.2010","article-title":"Hypersensitivity to mGluR5 and ERK1\/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome","volume":"30","author":"Osterweil","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104978_bb0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuron.2012.01.034","article-title":"Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome","volume":"77","author":"Osterweil","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2020.104978_bb0145","first-page":"64347","article-title":"Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs","volume":"2006","author":"Plante","year":"2006","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.nbd.2020.104978_bb0150","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1523\/JNEUROSCI.0093-05.2005","article-title":"Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse","volume":"25","author":"Qin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104978_bb0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/jcbfm.2012.205","article-title":"Altered cerebral protein synthesis in fragile X syndrome: studies in human subjects and knockout mice","volume":"33","author":"Qin","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2020.104978_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv034","article-title":"R-baclofen reverses a social behavior deficit and elevated protein synthesis in a mouse model of fragile X syndrome","volume":"18","author":"Qin","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2020.104978_bb0165","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.jcbfm.9600067","article-title":"Measurement of regional rates of cerebral protein synthesis with L-[1-11C]leucine and PET with correction for recycling of tissue amino acids: I. Kinetic modeling approach","volume":"25","author":"Schmidt","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2020.104978_bb0170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.jcbfm.9600066","article-title":"Measurement of regional rates of cerebral protein synthesis with L-[1-11C]leucine and PET with correction for recycling of tissue amino acids: II. Validation in rhesus monkeys","volume":"25","author":"Smith","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2020.104978_bb0175","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1093\/hmg\/ddv299","article-title":"Conserved hippocampal cellular pathophysiology but distinct behavioural deficits in a new rat model of FXS","volume":"24","author":"Till","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.104978_bb0180","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/jcbfm.2009.52","article-title":"Voxel-based estimation of kinetic model parameters of the L-[1-(11)C]leucine PET method for determination of regional rates of cerebral protein synthesis: validation and comparison with region-of-interest-based methods","volume":"29","author":"Tomasi","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2020.104978_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195580","article-title":"Effects of shortened scanning intervals on calculated regional rates of cerebral protein synthesis determined with the L-[1-11C]leucine PET method","volume":"13","author":"Tomasi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104978_bb0190","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1177\/0271678X18771242","article-title":"Substitution of venous for arterial blood sampling in the determination of regional rates of cerebral protein synthesis with L-[1-(11)C]leucine PET: a validation study","volume":"39","author":"Tomasi","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2020.104978_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13229-020-00350-5","article-title":"Elevated de novo protein synthesis in FMRP-deficient human neurons and its correction by metformin treatment","volume":"11","author":"Utami","year":"2020","journal-title":"Mol. Autism."},{"key":"10.1016\/j.nbd.2020.104978_bb0200","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/jcbfm.2010.26","article-title":"A spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET method","volume":"30","author":"Veronese","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.nbd.2020.104978_bb0205","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41598-017-18890-x","article-title":"Impact of tissue kinetic heterogeneity on PET quantification: case study with the L-[1-(11)C]leucine PET method for cerebral protein synthesis rates","volume":"8","author":"Veronese","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104978_bb0210","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0092-8674(01)00589-X","article-title":"Drosophila fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function","volume":"107","author":"Zhang","year":"2001","journal-title":"Cell"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:19:38Z","timestamp":1760851178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120302539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"alternative-id":["S0969996120302539"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104978","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional rates of brain protein synthesis are unaltered in dexmedetomidine sedated young men with fragile X syndrome: A L-[1-11C]leucine PET study","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104978"}}